Cargando…

Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis

PURPOSE: Chronic obstructive pulmonary disease (COPD) exacerbations are the leading cause of hospital admission and death among chronic bronchitis (CB) patients. This study estimated annual COPD exacerbation rates, related costs, and their predictors among patients treated for CB. METHODS: This was...

Descripción completa

Detalles Bibliográficos
Autores principales:	AbuDagga, Azza, Sun, Shawn X, Tan, Hiangkiat, Solem, Caitlyn T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624965/ https://www.ncbi.nlm.nih.gov/pubmed/23589684 http://dx.doi.org/10.2147/COPD.S40437

Ejemplares similares

Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis
por: AbuDagga, Azza, et al.
Publicado: (2014)

Cross-Sectional Analysis of the 1039 U.S. Physicians Reported to the National Practitioner Data Bank for Sexual Misconduct, 2003–2013
por: AbuDagga, Azza, et al.
Publicado: (2016)

Crossing the line: Sexual misconduct by nurses reported to the National Practitioner Data Bank
por: AbuDagga, Azza, et al.
Publicado: (2018)

760 Wholistic View of Autografting Patients by %TBSA Burned: Medical Chart Abstraction Integrated with Administrative Claims
por: Hahn, Helen D, et al.
Publicado: (2022)

Holistic View of Autografting Patients by Percentage of Total Body Surface Area Burned: Medical Record Abstraction Integrated with Administrative Claims
por: Hahn, Helen, et al.
Publicado: (2023)

Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease
por: Solem, Caitlyn T, et al.
Publicado: (2013)

Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
por: Solem, Caitlyn T, et al.
Publicado: (2016)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations
por: Ball, Peter
Publicado: (1995)

Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones
por: Mensa, J., et al.
Publicado: (2006)

Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis
por: Solem, Caitlyn T., et al.
Publicado: (2016)

Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims data
por: Chen, Yi, et al.
Publicado: (2019)

Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis
por: Jivcu, Cristian, et al.
Publicado: (2009)

A study of infective and other factors in exacerbations of chronic bronchitis
por: McHardy, Valentine U., et al.
Publicado: (1980)

Infection in acute exacerbations of chronic bronchitis: a clinical perspective
por: Read, R.C.
Publicado: (1999)

Development and Validation of an Algorithm to Identify Endometrial Adenocarcinoma in US Administrative Claims Data
por: Esposito, D. B., et al.
Publicado: (2019)

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population
por: Pasquale, Margaret K, et al.
Publicado: (2012)

Identification of pregnancies and infants within a US commercial healthcare administrative claims database
por: Bertoia, Monica L., et al.
Publicado: (2022)

Fluoroquinolone-Resistant Group B Streptococci in Acute Exacerbation of Chronic Bronchitis
por: Tazi, Asmaa, et al.
Publicado: (2008)

Antibacterials and Acute Exacerbation of Chronic Bronchitis: Issues for Formulary Decision Makers
por: Chock, Alan, et al.
Publicado: (2012)

Comparison of claims vs patient-reported adherence measures and associated outcomes among patients with nonvalvular atrial fibrillation using oral anticoagulant therapy
por: Stephenson, Judith J, et al.
Publicado: (2018)

Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data
por: Marvel, Jessica, et al.
Publicado: (2019)

Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database
por: Quint, Jennifer K., et al.
Publicado: (2021)

Viral and atypical pathogens as causes of type 1 acute exacerbations of chronic bronchitis
por: Roessingh, Peter H., et al.
Publicado: (2008)

Association of body mass index and COPD exacerbation among patients with chronic bronchitis
por: Shin, Sun Hye, et al.
Publicado: (2022)

Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
por: Cazzola, Mario, et al.
Publicado: (2015)

Development and validation of a predictive model to identify patients at risk of severe COPD exacerbations using administrative claims data
por: Annavarapu, Srinivas, et al.
Publicado: (2018)

Acute bronchitis: Results of U.S. and European trials of antibiotic therapy
por: Dere, Willard H.
Publicado: (1992)

Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
por: Jarosławski, Szymon, et al.
Publicado: (2018)

Predictors of latent tuberculosis infection treatment completion in the US private sector: an analysis of administrative claims data
por: Stockbridge, Erica L., et al.
Publicado: (2018)

Cost of peripheral neuropathy in patients receiving treatment for multiple myeloma: a US administrative claims analysis
por: Song, Xue, et al.
Publicado: (2019)

Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims
por: Chiuve, Stephanie E., et al.
Publicado: (2021)

RWD106 Characterizing Telehealth Utilization from Administrative Claims in the US Using a Standardized Definition
por: Avula, R, et al.
Publicado: (2022)

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis
por: Blasi, Francesco, et al.
Publicado: (2007)

SUN-604 U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims
por: McCandless, Shawn E, et al.
Publicado: (2020)

Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey
por: Solem, Caitlyn T, et al.
Publicado: (2014)

Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
por: Solem, Caitlyn T., et al.
Publicado: (2014)

Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population
por: Kern, David M, et al.
Publicado: (2015)

Persistence with weekly and monthly bisphosphonates among postmenopausal women: analysis of a US pharmacy claims administrative database
por: Fan, Tao, et al.
Publicado: (2013)

Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set
por: Walsh, Jessica A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hin61ten13agifcoru0q5al0pj